Ozempic
-
healthGLP-1 Weight Loss Drugs Drive Surge in Cosmetic Body Contouring Procedures
Rapid weight loss from GLP-1 medications like Ozempic is causing sagging skin and volume loss, prompting a significant increase in plastic surgery and body contouring procedures nationwide.
-
healthGLP-1 Users Reduce Physical Activity Despite Muscle Loss Risks
New research presented at ENDO 2026 reveals GLP-1 users significantly decrease exercise, risking lean muscle mass. Experts emphasize mandatory resistance training and clinical oversight for safe weight management.
-
healthGLP-1 Drugs Linked to Lower Breast Cancer Risk and Better Outcomes
Observational studies show GLP-1 meds like Ozempic may reduce breast cancer incidence by 30% and improve survival rates.
-
healthGLP-1 Drugs May Cut Breast Cancer Risk by 30%, Study Finds
GLP-1 medications like Ozempic and Mounjaro may reduce breast cancer risk by up to 30%, independent of weight loss, new research shows.
-
healthCanada Approves Generic Ozempic; US Waits Until 2032
Canada becomes first G7 nation to approve generic semaglutide. US patients face patent barriers until 2032, sparking cross-border interest.
-
healthGLP-1 Drugs Like Ozempic Show Broad Cancer Protection Promise
Multiple studies at ASCO 2024 show GLP-1 drugs reduce cancer risk and improve outcomes across tumor types, with potential benefits tied to inflammation reduction and weight loss.
-
healthAI Analysis of Reddit Posts Reveals Potential Hidden Side Effects of Ozempic
Researchers used AI to analyze Reddit posts, uncovering unreported side effects of GLP-1 drugs like Ozempic and Wegovy.
-
healthExercise Boosts Ozempic Benefits, Preserves Muscle in Obesity Study
New research at EAS 2026 shows combining semaglutide with exercise preserves muscle and enhances fat loss.